These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 37243158)

  • 1. The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence.
    Buchynskyi M; Kamyshna I; Oksenych V; Zavidniuk N; Kamyshnyi A
    Viruses; 2023 Apr; 15(5):. PubMed ID: 37243158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 Pandemic: Insights into Interactions between SARS-CoV-2 Infection and MAFLD.
    Chen H; Chen Q
    Int J Biol Sci; 2022; 18(12):4756-4767. PubMed ID: 35874945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management.
    Xu Y; Yang X; Bian H; Xia M
    Lipids Health Dis; 2021 Oct; 20(1):126. PubMed ID: 34602072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of COVID-19 in patients with metabolic-associated fatty liver disease.
    Jeeyavudeen MS; Chaudhari R; Pappachan JM; Fouda S
    World J Gastroenterol; 2023 Jan; 29(3):487-502. PubMed ID: 36688018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronavirus disease 2019 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight.
    Vasques-Monteiro IML; Souza-Mello V
    World J Gastroenterol; 2021 Apr; 27(16):1738-1750. PubMed ID: 33967554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-alcoholic Fatty Liver Disease and COVID-19 Susceptibility and Outcomes: a Korean Nationwide Cohort.
    Yoo HW; Jin HY; Yon DK; Effenberger M; Shin YH; Kim SY; Yang JM; Kim MS; Koyanagi A; Jacob L; Smith L; Yoo IK; Shin JI; Lee SW
    J Korean Med Sci; 2021 Oct; 36(41):e291. PubMed ID: 34697932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19, adaptative immune response and metabolic-associated liver disease.
    Miele L; Napodano C; Cesario A; De Magistris A; Pocino K; Basile U; Rapaccini GL; Gasbarrini A; Grieco A
    Liver Int; 2021 Nov; 41(11):2560-2577. PubMed ID: 34555255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipose tissue dysfunction and MAFLD in obesity on the scene of COVID-19.
    Cordeiro A; Ribamar A; Ramalho A
    Clin Res Hepatol Gastroenterol; 2022 Mar; 46(3):101807. PubMed ID: 34543756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronavirus disease 2019 and non-alcoholic fatty liver disease.
    Bellanti F; Vendemiale G
    World J Hepatol; 2021 Sep; 13(9):969-978. PubMed ID: 34630869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association and Interaction Between Serum Interleukin-6 Levels and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients With Severe Coronavirus Disease 2019.
    Gao F; Zheng KI; Yan HD; Sun QF; Pan KH; Wang TY; Chen YP; Targher G; Byrne CD; George J; Zheng MH
    Front Endocrinol (Lausanne); 2021; 12():604100. PubMed ID: 33763027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate and Adaptive Immunity Alterations in Metabolic Associated Fatty Liver Disease and Its Implication in COVID-19 Severity.
    Lamadrid P; Alonso-Peña M; San Segundo D; Arias-Loste M; Crespo J; Lopez-Hoyos M
    Front Immunol; 2021; 12():651728. PubMed ID: 33859644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Associated Fatty Liver Disease Is Associated With an Increased Risk of Severe COVID-19: A Systematic Review With Meta-Analysis.
    Hegyi PJ; Váncsa S; Ocskay K; Dembrovszky F; Kiss S; Farkas N; Erőss B; Szakács Z; Hegyi P; Pár G
    Front Med (Lausanne); 2021; 8():626425. PubMed ID: 33777974
    [No Abstract]   [Full Text] [Related]  

  • 13. MAFLD in COVID-19 patients: an insidious enemy.
    Dongiovanni P; Meroni M; Longo M; Fracanzani AL
    Expert Rev Gastroenterol Hepatol; 2020 Oct; 14(10):867-872. PubMed ID: 32705906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 and non-alcoholic fatty liver disease: Two intersecting pandemics.
    Portincasa P; Krawczyk M; Smyk W; Lammert F; Di Ciaula A
    Eur J Clin Invest; 2020 Oct; 50(10):e13338. PubMed ID: 32589264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic dysfunction associated fatty liver disease increases risk of severe Covid-19.
    Sharma P; Kumar A
    Diabetes Metab Syndr; 2020; 14(5):825-827. PubMed ID: 32540736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic associated fatty liver disease increases the severity of COVID-19: A meta-analysis.
    Pan L; Huang P; Xie X; Xu J; Guo D; Jiang Y
    Dig Liver Dis; 2021 Feb; 53(2):153-157. PubMed ID: 33011088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of metabolic dysfunction-associated fatty liver disease and nonalcoholic fatty liver disease with advanced fibrosis in the death and intubation of patients hospitalized with coronavirus disease 2019.
    Vázquez-Medina MU; Cerda-Reyes E; Galeana-Pavón A; López-Luna CE; Ramírez-Portillo PM; Ibañez-Cervantes G; Torres-Vázquez J; Vargas-De-León C
    Hepatol Commun; 2022 Aug; 6(8):2000-2010. PubMed ID: 35438253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic-associated fatty liver disease is associated with severity of COVID-19.
    Zhou YJ; Zheng KI; Wang XB; Sun QF; Pan KH; Wang TY; Ma HL; Chen YP; George J; Zheng MH
    Liver Int; 2020 Sep; 40(9):2160-2163. PubMed ID: 32573883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 and MAFLD/NAFLD: An updated review.
    Nowroozi A; Momtazmanesh S; Rezaei N
    Front Med (Lausanne); 2023; 10():1126491. PubMed ID: 37035343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infections at the nexus of metabolic-associated fatty liver disease.
    Boeckmans J; Rombaut M; Demuyser T; Declerck B; Piérard D; Rogiers V; De Kock J; Waumans L; Magerman K; Cartuyvels R; Rummens JL; Rodrigues RM; Vanhaecke T
    Arch Toxicol; 2021 Jul; 95(7):2235-2253. PubMed ID: 34027561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.